• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,664.21 -999.79
( -1.29%)
Global Indices
Nasdaq
49,249.13 -82.20
(-0.17%)
Dow Jones
7,185.72 56.32
(0.79%)
Hang Seng
59,744.07 603.84
(1.02%)
Nikkei 225
10,387.94 -69.07
(-0.66%)
Forex
USD-INR
94.05 0.29
(0.31%)
EUR-INR
109.99 0.01
(0.01%)
GBP-INR
126.84 0.17
(0.14%)
JPY-INR
0.59 0.00
(0.16%)

EQUITY - MARKET SCREENER

Natco Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524816
INE987B01026
461.79599
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATCOPHARM
13.04
19566.86
EPS(TTM)
Face Value()
Div & Yield %
83.75
2
0.55
 

jamshri realty ltd
Hindustan Zinc climbs after emerging as top bidder for Rajasthan mineral block
Apr 15,2026
The tender was part of Tranche V of auctions for critical and strategic mineral blocks, where composite licenses were offered through an online bidding process.

The company secured the block with the highest final price offer of 3.05%, as per a notification dated 12 April 2026. The Jhandawali – Satipura Amalgamated Potash and Halite Block is at G3 level of exploration with total area of 1841.22 hectares for the block.

Hindustan Zinc, part of the Vedanta Group, is the world’s largest integrated zinc producer and among the top five silver producers globally. The company exports to more than 40 countries and holds around 77% share of India’s primary zinc market.

The company’s consolidated net profit jumped 46.23% to Rs 3916 crore while net sales rose 27.81% to Rs 10627 crore in Q3 December 2025 over Q3 December 2024.